The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications
Open accessAbstract
Research in the area of pulmonary drug delivery has gathered momentum in the last several years, with increased interest in using the lung as a means of delivering drugs systemically. Advances in device technology have led to the development of more efficient delivery systems capable of delivering larger doses and finer particles into the lung. As more efficient pulmonary delivery devices and sophisticated formulations become available, physicians and health professionals will have a choice of a wide variety of device and formulation combinations that will target specific cells or regions of the lung, avoid the lung's clearance mechanisms and be retained within the lung for longer periods. It is now recognized that it is not enough just to have inhalation therapy available for prescribing; physicians and other healthcare providers need a basic understanding of aerosol science, inhaled formulations, delivery devices, and bioequivalence of products to prescribe these therapies optimally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prigogine, I., Stengers, I., & Pagels, H. R. (1984) · Cited by 2,468
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
CLARK, A. R., & HOLLINGWORTH, A. M. (1993) · Journal of Aerosol Medicine · doi:10.1089/jam.1993.6.99 · Cited by 332
Newman, S. P., Weisz, A. W., Talaee, N., & Clarke, S. W. (1991) · Thorax · doi:10.1136/thx.46.10.712 · Cited by 326
The science of nebulised drug delivery
O'Callaghan, C., & Barry, P. W. (1997) · Thorax · doi:10.1136/thx.52.2008.s31 · Cited by 293
Borgstrom, L., Bondesson, E., Moren, F., Trofast, E., & Newman, S. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07010069 · Cited by 289
Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
Allen, T. M. (1998) · Drugs · doi:10.2165/00003495-199856050-00001 · Cited by 283
Systemic Effect Comparisons of Six Inhaled Corticosteroid Preparations
Martin, R. J., Szefler, S. J., Chinchilli, V. M., Kraft, M., Dolovich, M., Boushey, H. A., Cherniack, R. M., Craig, T. J., Drazen, J. M., Fagan, J. K., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105013 · Cited by 256
Self-citationEschenbacher, W. L., Boushey, H. A., & Sheppard, D. (1984) · PubMed · Cited by 241
Cited by
Influence of particle size on regional lung deposition – What evidence is there?
Carvalho, T. C., Peters, J. I., & Williams III, R. O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.040 · Cited by 614
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Corsonello, A., Pedone, C., & Incalzi, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416326 · Cited by 391
Inhalation drug delivery devices: technology update
Garcia-Contreras, L., Ibrahim, M., & Verma, R. (2015) · Medical Devices: Evidence and Research · doi:10.2147/mder.s48888 · Cited by 306
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.020 · Cited by 245
Metadata
- Authors
- Labiris, N. R., & Dolovich, M. B.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2003-08-20
- Volume
- 56
- Issue
- 6
- Pages
- 600-612
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1575908580
- Cited by
- 451
- References
- 39
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. https://app.cochat.ai/papers/10.1046/j.1365-2125.2003.01893.x
- The paper
- Labiris, N. R., & Dolovich, M. B. (2003). Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.2003.01893.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
